SG/CALL/VERTEX PHARMACEUTICALS/540/0.1/20.09.24

SG/CALL/VERTEX PHARMACEUTICALS/540/0.1/20.09.24 Stock

DE000SU7GDE1

Market Closed - Boerse Frankfurt Warrants 15:49:27 2024-05-24 EDT
0.6 ^EUR	+11.11%

Current month	+100.00%
1 month	+71.43%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart VERTEX PHARMACEUTICALS INCORPORATED

Chart SG/CALL/VERTEX PHARMACEUTICALS/540/0.1/20.09.24

Latest news about VERTEX PHARMACEUTICALS INCORPORATED

Vertex Pharmaceuticals Insider Sold Shares Worth $3,168,704, According to a Recent SEC Filing	05-24	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing	05-22	MT
Vertex to Participate in Upcoming June Investor Conferences	05-22	BU
ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment	05-21	MT

More news

Quotes 5-day view

Date	Price	Change
24-05-24	0.6	+11.11%
24-05-23	0.54	+10.20%
24-05-22	0.49	+22.50%
24-05-21	0.4	-14.89%
24-05-20	0.47	+6.82%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 03:49 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	VERTEX PHARMACEUTICALS INCORPORATED
Issuer	Société Générale
WKN	SU7GDE
ISIN	DE000SU7GDE1
Date issued	2024-01-25
Strike	540 $
Maturity	2024-09-20 (118 Days)
Parity	10 : 1
Emission price	1.37 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.55 €
Lowest since issue	0.072 €
Spread	0.02 €
Spread %	3.17%

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).

Sector

More about the company